Back to results
US 2025/0144105 A1Published application
Cdk9 inhibitors
AssigneeOrigenis GmbH
InventorsRoland Köstler, Jean Tassel, Michael Thormann
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel compounds of formula (I): These compounds are inhibitors of CDK9 and are useful in the treatment of a variety of diseases including hyperproliferative diseases, virally induced infectious diseases, and cardiovascular diseases.
Claims21
A compound of formula (I):
- wherein
- R1 is an alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, heterocycloalkyl, alkylcycloalkyl, heteroalkylcycloalkyl, aryl, heteroaryl, aralkyl or heteroaralkyl group;
- all of which groups may optionally be substituted;
- R2 is a phenyl group that is substituted by 1, 2 or 3 substituents that are independently selected from the group consisting of F, Cl, Br and Me;
- and
- R3 is a halogen atom, CN, a C1-4 alkyl group or a C1-4 heteroalkyl group;
- or a salt or a solvate thereof.
4 more elements
-25. (canceled)
Dependencies are inferred from the claim text.